|
1. Gerber MA, Hadziyannis S, Vissoulis C, Schaffner F, Paronetto F, Popper H. Electron microscopy and immune electron microscopy of cytoplasmic hepatitis B antigen in hepatocytes. Am J Pathol 1974; 75(3): 489–502. 2. Fattovich G. Natural history and prognosis of hepatitis B. Semin Liver Dis 2003; 23(1): 47–58. 3. Hadziyannis SJ, Papatheodoridis GV. Hepatitis B antigen negative chronic hepatitis B natural history and treatment. Semin Liver Dis 2006; 26(2): 130–41. 4. Wang S, Zhu C, Zhang R, Liu L, WU J. Association of interleukin 27 expression and p28 gene polymorphism with chronic hepatitis B virus infection. J Toxicol Environ Health Sci 2009; 1(2): 028–33. 5. Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002; 16(6): 779–90. 6. Trinchieri G, Pflanz S, Kastelein RA. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003; 19(5): 641–4. 7. Stumhofer JS, Hunter CA. Advances in understanding the anti-inflammatory properties of IL-27. Immunol Lett 2008; 117(2): 123–30. 8. Pflanz, S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002; 16(6): 779–90. 9. Awasthi A, Carrier Y, Peron JP, Bettelli E, Kamanaka M, Flavell RA, et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 2007; 8(12): 1380–9. 10. Chiyo M, Shimozato O, Yu L, Kawamura K, Iizasa T, Fujisawa T, et al. Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. Int J Cancer 2005; 115(3): 437–42. 11. Mayer KD, Mohrs K, Reiley W, Wittmer S, Kohlmeier JE, Pearl JE, et al. Cutting edge: T-bet and IL-27R are critical for in vivo IFN-gamma production by CD8 T cells during infection. J Immunol 2008; 180(2): 693–7. 12. Hibbert L, Pflanz S, De Waal Malefyt R, Kastelein RA. IL-27 and IFN alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J Interferon Cytokine Res 2003; 23(9): 513–22. 13. Yoshida H, Nakaya M, Miyazaki Y. Interleukin 27: a double-edged sword for offense and defense. J Leukocyte Biol 2009; 86(6): 1295-303. 14. Hunter CA. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 2005; 5(7): 521–31. 15. Lucas S, Ghilardi N, Li J, de Sauvage FJ. IL-27 regulates IL-12 responsiveness of naive CD4 T cells through Stat1-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 2003; 100(25): 15047–52. 16. Peng Q, Qin X, He Y, Chen Z, Deng Y, Li T, et al. Association of IL27 gene polymorphisms and HBV-related hepatocellular carcinoma risk in a Chinese population. Infect Genet Evol 2013; 16: 1-4. 17. Chong WP, To YF, Ip WK, Yuen MF, Poon TP, Wong WH, et al. Mannose-binding lectin in chronic hepatitis B virus infection. Hepatology 2005; 42(5): 1037–45. 18. Basturk B, Karasu Z, Kilic M, Ulukaya S, Boyacioglu S, Oral B. Association of TNF-alpha - 308 polymorphism with the outcome of hepatitis B virus infection in Turkey. Infect Genet Evol 2008; 8(1): 20-5. 19. Naghoosi H, Mohebbi SR, Tahaei SME, Azimzadeh P, Romani S, Almasi S, et al. Evaluating the relationship between single-nucleotide polymorphism in the TNF-gene promoter and susceptibility to chronic hepatitis B infection in patients referring to Taleghani hospital in Tehran. Feyz 2013; 16(6): 522-8. [in Persian] 20. Hong MH, Chu YC, Wu YC, Tsai KN, Hu CP, Jeng KS, et al. Transforming growth Factor-beta1 suppresses hepatitis B virus replication by the reduction of hepatocyte nuclear factor-4alpha expression. PLoS One 2012; 7(1): e30360. 21. Hosseini A, Hosseini SM, Azimzadeh P, Mohebbi SR, Khanyaghma M, Sharifian A, et al. The Assosiation of Promoter Polymorphism of TGF-_1 (-509C>T) with Chronic Hepatitis B in Iraninan Patients Referred to Taleghani Hospital, Tehran. J Kerman Univ Med Sci 2013; 20(3): 223-31. [in Persian] 22. Ali YB, El-Masry SA, El-Akhras BA, El-Shenawy SZ, El-Sayed IH. Association of Interleukin 27 gene polymorphism and risk of Hepatitis B viral infection in Egyptian population. Egyptian J Med Human Genetics 2014; 15(1): 53–9. 23. Van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LA, Gilissen C, et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med 2011; 365(1): 54–61. 24. Huang N, Liu L, Wang XZ, Liu D, Yin SY, Yang XD. Association of interleukin (IL)-12 and IL-27 gene polymorphisms with chronic obstructive pulmonary disease in a Chinese population. DNA Cell Biol 2008; 27(9): 527–31. 25. Li CS, Zhang Q, Lee KJ, Cho SW, Lee KM, Hahm KB, et al. Interleukin-27 polymorphisms are associated with inflammatory bowel diseases in a Korean population. J Gastroenterol Hepatol 2009; 24(10): 1692–16. 26. Zhang YF, Zhao AD. Common Polymorphisms in IL-27 Genes May Contribute to Risk of Various Human Diseases in Asian Populations: A Meta-Analysis. Med Sci Monit 2016; 7(22):766-75.
|
.png)
.png){kind=logo}
